Imaging of prostate cancer

Radiol Clin North Am. 2007 Jan;45(1):207-22. doi: 10.1016/j.rcl.2006.10.008.

Abstract

The role of imaging in the diagnosis and management of prostate is reviewed. Transrectal ultrasonography, which can be used to guide biopsy, is most frequently used imaging technique in cancer detection. For determining the extent of disease, CT and MR imaging are the most commonly used modalities; bone scintigraphy and positron emission tomography have roles only in advanced disease. Currently, the role of imaging in prostate cancer is evolving to improve disease detection and staging, to determine the aggressiveness of disease, and to predict outcomes in different patient populations

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Age Factors
  • Aged
  • Antibodies, Monoclonal
  • Biopsy, Needle
  • Bone Neoplasms / diagnosis
  • Bone Neoplasms / diagnostic imaging
  • Bone Neoplasms / secondary
  • Follow-Up Studies
  • Humans
  • Indicators and Reagents
  • Lymphatic Metastasis / diagnosis
  • Lymphatic Metastasis / pathology
  • Magnetic Resonance Imaging*
  • Magnetic Resonance Spectroscopy*
  • Male
  • Middle Aged
  • Neoplasm Metastasis / diagnosis
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Staging
  • Physical Examination
  • Positron-Emission Tomography*
  • Prognosis
  • Prostate / pathology
  • Prostate-Specific Antigen / blood
  • Prostatectomy
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy
  • Prostatic Neoplasms / surgery
  • ROC Curve
  • Radiotherapy, Adjuvant
  • Risk Factors
  • Tomography, X-Ray Computed*
  • Treatment Outcome
  • Ultrasonography

Substances

  • Antibodies, Monoclonal
  • Indicators and Reagents
  • Capromab Pendetide
  • Prostate-Specific Antigen